The Effect Of Profitability On Stock Price In Pharmaceutical Sub-Sector Companies Listed On The Indonesia Stock Exchange (Idx) Period 2017 – 2021

Abstract

The pharmaceutical industry is one of the industries that is quite in demand to conduct investment activities throughout the Covid-19 pandemic. This is due to the increasing demand and public need for health products. In analyzing stocks, there are 2 basic approaches, namely technical analysis and fundamental analysis. Investors frequently use fundamental analysis to evaluate a a company's performance can be determined by scrutinising its financial statements. The financial ratios of the company reflect the company's financial performance. This study aims to ascertain the effect of profitability on the stock prices of pharmaceutical companies listed on the IDX between 2017 and
2021. This study employs quantitative data categories derived from secondary sources such as literature studies, published company financial statements, and published literature. Using a technique of sampling known as purposive sampling, this study's population data were collected was obtained by five pharmaceutical companies from pharmaceutical companies registered on the IDX. Pharmaceutical company stock prices are substantially influenced by Return On Asset (ROA) and Earnings Per Share (EPS) between 2017 and 2021, according to this study